Semaglutide use in patients with type 2 diabetes (T2D) slightly increases the risk of nonarteritic anterior ischemic optic neuropathy (NAION), research published in JAMA Ophthalmology shows. The study ...

Opens in a new tab or window Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than ...

Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. Cindy X. Cai, M.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues conducted a ...

Non-arteritic anterior ischemic optic neuropathy (NAION) - also known as a "eye stroke" - typically causes sudden vision loss in one eye. It occurs from a lack of sufficient blood flow to the ...

Semaglutide was tied to nonarteritic anterior ischemic optic neuropathy (NAION) risk vs. nonuse in adults with type 2 diabetes. New semaglutide users did not have higher NAION risk vs. most other ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says. Patients on ...

But, after getting a CT-scan and seeing a neuro-ophthalmologist, it was revealed he had non-arteritic anterior ischemic optic neuropathy (NAION), a condition in which the loss of blood flow to the ...

NAION causes sudden vision loss in one eye due to damaged optic nerves MONDAY, Feb. 24, 2025 (HealthDay News) -- People taking the weight-loss drug semaglutide could be at a slightly increased risk ...

为探究司美格鲁肽（semaglutide）与非动脉炎性前部缺血性视神经病变（NAION）关联，研究分析 4 例患者，发现小 Bruch 膜开口或有风险。 在当今社会，随着人们生活方式的改变和对健康关注度的提升，各种新型药物不断涌现，用于治疗各类疾病。司美格鲁肽 ...